Cresp 40mcg Darbepoetin ALFA Injection

Cresp 40mcg Darbepoetin Alfa Injection is a prescription medication used to treat anemia associated with chronic kidney disease (CKD) and anemia caused by certain chemotherapy treatments. It contains Darbepoetin Alfa, a long-acting erythropoiesis-stimulating agent (ESA) that works by stimulating the bone marrow to produce more red blood cells. By increasing red blood cell production, Cresp 40mcg Darbepoetin Alfa Injection helps improve oxygen delivery throughout the body, reducing symptoms such as fatigue, weakness, dizziness, and shortness of breath. Administered as a subcutaneous or intravenous injection under the supervision of a healthcare professional, it plays an important role in managing anemia and improving overall quality of life. Regular monitoring of hemoglobin levels is essential during treatment to ensure safe and effective use. Patients should use Cresp 40mcg Injection only as directed by their healthcare provider.